Open AccessReduction of soluble CD163, substance P, programmed death 1 and inflammatory markers
Author(s) -
Pablo Tebas,
Sergei Spitsin,
Jeffrey S. Barrett,
Florin Tuluc,
Okan U. Elci,
James Korelitz,
Wayne Wagner,
Angela Winters,
Deborah Kim,
Renae Catalano,
Dwight L. Evans,
Steven D. Douglas
Publication year - 2015
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000000638
Subject(s) - aprepitant , medicine , placebo , pharmacology , substance p , gastroenterology , receptor , chemotherapy , antiemetic , pathology , neuropeptide , alternative medicine
We evaluated safety, antiviral, immunomodulatory and anti-inflammatory properties of aprepitant - a neurokinin 1 receptor antagonist.